Plasma proteomics and machine learning deliver non-invasive distinction between fibrotic hypersensitivity pneumonitis and idiopathic pulmonary fibrosis.
A blood test using machine learning can distinguish two hard-to-tell-apart lung diseases without needing surgery, sparing some patients invasive biopsies.
A plasma proteomics combined with machine learning approach accurately distinguished fibrotic hypersensitivity pneumonitis (FHP) from idiopathic pulmonary fibrosis (IPF) non-invasively, with validation in an independent cohort. This non-invasive classifier could reduce the need for surgical lung biopsy in diagnostically challenging ILD patients.
What the study was
- Study design
- ml_biomarker_discovery_and_validation
- Category
- ai_ml_diagnostics
- Maturity
- Validated
Why it surfaced
Novel plasma proteomics + ML approach solving a real clinical diagnostic problem (FHP vs. IPF) where accurate classification drives treatment decisions. Relevant to AI/ML diagnostics watchlist. Validated in independent cohort; open-access publication in J Transl Med.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.